MATTER Startup Shoutouts: January 29, 2021

Every day, innovators across the MATTER community are building new solutions that accelerate innovation, advance care and improve lives. Here’s a look into some of the most noteworthy headlines from the startup members in our community over the past month.

Dina raises $7 million in a Series A funding round

Dina, an AI-powered care-at-home platform and network, recently announced $7 million in a recent funding round led by Osage Venture Partners. The funding will be used to accelerate the development and expansion of Dina’s care coordination platform to support the healthcare industry’s rapid transition to virtual and in-home care.

Pear Therapeutics partners with Groups Recover Together

Pear Therapeutics, an FDA cleared prescription digital therapeutics company, announced their partnership with Groups Recover Together. With Pear’s reSET-O®, an FDA-authorized prescription digital therapeutics technology and Group’s unparalleled approach to treatment, this partnership will be a driver in the effort to improve treatment for people with opioid use disorder.

PhysIQ enters into phase II of contract with National Institutes of Health

PhysIQ, developer of the first FDA 510k-cleared personalized physiology data analytics platform, entered into phase II of their contract with the NIH to develop a COVID-19 digital biomarker bringing the contract to a total of $6.6 million. In this next phase, physIQ will begin validation of the biomarker and monitor more than 1,200 patients. During the validation period, physIQ will continue to enroll ambulatory participants who are COVID-19 positive and evaluate the ability for the digital biomarker to predict decompensation severity remote from the hospital.

Interested in learning about the newest members of the MATTER startup community? Check them out here.